Allianz SE
OTC:ALIZF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allianz SE
OTC:ALIZF
|
DE |
|
A
|
Acen Corp
XPHS:ACEN
|
PH |
|
U
|
United Airlines Holdings Inc
SWB:UAL1
|
US |
|
C
|
Corteva Inc
XETRA:2X0
|
US |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
C
|
COSCO Shipping Holdings Co Ltd
SWB:C6G
|
CN |
|
Banco Bilbao Vizcaya Argentaria SA
MAD:BBVA
|
ES |
|
Thales SA
F:CSF0
|
FR |
|
I
|
IDEXX Laboratories Inc
LSE:0J8P
|
US |
|
T
|
Tuya Inc
F:785
|
CN |
|
ING Groep NV
NYSE:ING
|
NL |
|
P
|
Post Holdings Inc
SWB:2PO
|
US |
|
Ferguson Enterprises Inc
F:UH3
|
US |
|
Acarix AB
OTC:ACIXF
|
SE |
|
D
|
Danaher Corp
BMV:DHR
|
US |
|
Hermes International SCA
XETRA:HMI
|
FR |
|
F
|
Fiserv Inc
XETRA:FIV
|
US |
|
ICICI Bank Ltd
NSE:ICICIBANK
|
IN |
|
I
|
International Consolidated Airlines Group SA
SWB:INR
|
UK |
|
A
|
Amazon.com Inc
DUS:AMZ
|
US |
|
China Petroleum & Chemical Corp
F:CHU
|
CN |
|
H
|
Harvard Bioscience Inc
F:HBI
|
US |
|
E
|
EcoSynthetix Inc
OTC:ECSNF
|
CA |
|
Consti Oyj
LSE:0RD9
|
FI |
Wall St Price Targets
ALIZF Price Targets Summary
Allianz SE
According to Wall Street analysts, the average 1-year price target for ALIZF is 488.34 USD with a low forecast of 390.04 USD and a high forecast of 628.82 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALIZF's stock price target?
Price Target
488.34
USD
According to Wall Street analysts, the average 1-year price target for ALIZF is 488.34 USD with a low forecast of 390.04 USD and a high forecast of 628.82 USD.
What is the Revenue forecast for Allianz SE?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Allianz SE?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 8 years is 7%.
